237 related articles for article (PubMed ID: 9080892)
1. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapy.
Baranda L; Torres-Alvarez B; Cortes-Franco R; Moncada B; Portales-Perez DP; Gonzalez-Amaro R
Arch Dermatol; 1997 Mar; 133(3):325-9. PubMed ID: 9080892
[TBL] [Abstract][Full Text] [Related]
2. The effect of methotrexate on the expression of cell adhesion molecules and activation molecule CD69 in psoriasis.
Torres-Alvarez B; Castanedo-Cazares JP; Fuentes-Ahumada C; Moncada B
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):334-9. PubMed ID: 17309454
[TBL] [Abstract][Full Text] [Related]
3. Immunopathologic study of erythema dyschromicum perstans (ashy dermatosis).
Vásquez-Ochoa LA; Isaza-Guzmán DM; Orozco-Mora B; Restrepo-Molina R; Trujillo-Perez J; Tapia FJ
Int J Dermatol; 2006 Aug; 45(8):937-41. PubMed ID: 16911378
[TBL] [Abstract][Full Text] [Related]
4. Adhesion molecule expression and endothelial cell activation in cutaneous leukocytoclastic vasculitis. An immunohistologic and clinical study in 42 patients.
Sais G; Vidaller A; Jucglá A; Condom E; Peyrí J
Arch Dermatol; 1997 Apr; 133(4):443-50. PubMed ID: 9126007
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods.
Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Mazurkiewicz L; Skwarek M; Walczak E; Michalak E; Cedro K; Chmielak Z; Debski A; Demkow M; Witkowski A; Wagner T; Ruzyłło W
Kardiol Pol; 2006 May; 64(5):479-87; discussion 488. PubMed ID: 16752331
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial with clofazimine for treating erythema dyschromicum perstans. Evaluation of cell-mediated immunity.
Piquero-Martín J; Pérez-Alfonzo R; Abrusci V; Briceño L; Gross A; Mosca W; Tapia F; Convit J
Int J Dermatol; 1989 Apr; 28(3):198-200. PubMed ID: 2785092
[TBL] [Abstract][Full Text] [Related]
7. In-situ endothelial cell adhesion molecule expression in ulcerative colitis. E-selectin in-situ expression correlates with clinical, endoscopic and histological activity and outcome.
Cellier C; Patey N; Fromont-Hankard G; Cervoni JP; Leborgne M; Chaussade S; Barbier JP; Brousse N
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1197-203. PubMed ID: 9471026
[TBL] [Abstract][Full Text] [Related]
8. Erythema dyschromicum perstans: response to dapsone therapy.
Bahadir S; Cobanoglu U; Cimsit G; Yayli S; Alpay K
Int J Dermatol; 2004 Mar; 43(3):220-2. PubMed ID: 15009398
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR association with the genetic susceptibility to develop ashy dermatosis in Mexican Mestizo patients.
Correa MC; Memije EV; Vargas-Alarcón G; Guzmán RA; Rosetti F; Acuña-Alonzo V; Martínez-Rodríguez N; Granados J
J Am Acad Dermatol; 2007 Apr; 56(4):617-20. PubMed ID: 17116345
[TBL] [Abstract][Full Text] [Related]
10. [Erythema cinitiensis perstans].
Sittart JA; Tayah M
Med Cutan Ibero Lat Am; 1980; 8(1-3):11-4. PubMed ID: 7022047
[TBL] [Abstract][Full Text] [Related]
11. Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo.
Gross A; Tapia FJ; Mosca W; Perez RM; Briceño L; Henriquez JJ; Convit J
Histol Histopathol; 1987 Jul; 2(3):277-83. PubMed ID: 2980730
[TBL] [Abstract][Full Text] [Related]
12. [Erythema dyschromicum perstans versus lichen planus].
Leonforte JL; Peláez de di Bari O
Med Cutan Ibero Lat Am; 1987; 15(1):89-92. PubMed ID: 3298889
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical study of UV-induced skin lesions in actinic prurigo. Resistance of langerhans cells to UV light.
Torres-Alvarez B; Baranda L; Fuentes C; Delgado C; Santos-Martinez L; Portales-Perez D; Moncada B; Gonzalez-Amaro R
Eur J Dermatol; 1998; 8(1):24-8. PubMed ID: 9649710
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis.
Lundberg I; Kratz AK; Alexanderson H; Patarroyo M
Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873
[TBL] [Abstract][Full Text] [Related]
15. Erythema dyschromicum perstans. Immunopathologic studies.
Miyagawa S; Komatsu M; Okuchi T; Shirai T; Sakamoto K
J Am Acad Dermatol; 1989 May; 20(5 Pt 2):882-6. PubMed ID: 2785541
[TBL] [Abstract][Full Text] [Related]
16. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
[TBL] [Abstract][Full Text] [Related]
17. Erythema dyschromicum perstans: a case report and review.
Osswald SS; Proffer LH; Sartori CR
Cutis; 2001 Jul; 68(1):25-8. PubMed ID: 11480143
[TBL] [Abstract][Full Text] [Related]
18. Erythema Dyschromicum Perstans: Response to Topical Tacrolimus.
Mahajan VK; Chauhan PS; Mehta KS; Sharma AL
Indian J Dermatol; 2015; 60(5):525. PubMed ID: 26538750
[TBL] [Abstract][Full Text] [Related]
19. Erythema dyschromicum perstans in phototype II women: three unusual clinical cases studied with electron microscopy.
Persechino S; Caperchi C; Cortesi G; Persechino F; Raffa S; Pulcini F; Tammaro A; Torrisi MR
Eur J Dermatol; 2011; 21(2):261-2. PubMed ID: 21382781
[No Abstract] [Full Text] [Related]
20. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study.
Kroon MW; Wind BS; Meesters AA; Wolkerstorfer A; van der Veen JP; Bos JD; Van der Wal AC; Beek JF
J Dermatolog Treat; 2012 Oct; 23(5):339-44. PubMed ID: 21756152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
